Skip to content

A clinical study for evaluating the effects of food containing lactic acid bacteria on intestinal environment. - A randomized, double-blind, placebo-controlled, parallel-group comparative method -

A clinical study for evaluating the effects of food containing lactic acid bacteria on intestinal environment. - A randomized, double-blind, placebo-controlled, parallel-group comparative method - - A clinical study for evaluating the effects of food containing lactic acid bacteria on intestinal environment.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048914
Enrollment
80
Registered
2023-12-04
Start date
2022-10-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects with a tendency for constipation

Interventions

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese males and females aged from 20 and 64 years old 2. Subjects with bowel movements between 3 to 5 times a weeks at the point of screening examination 3. Subjects having an ability to understand study purpose and detail with voluntary written informed consent

Exclusion criteria

Exclusion criteria: Subjects(who) 1. suffering from, undergoing treatment for, or with a history of serious diseases 2. have a chronic diseases and take medication on a daily basis 3. consume medication that potentially affect the intestinal environment on a daily basis 4. consume foods that potentially affect the intestinal environment more than 5 times a week 5. are unable to abstain from taking foods that potentially affect the intestinal environment. 6. have taken antibiotics within 2 weeks before the point of screening examination 7. perform high-intensity exercise intended for muscle building more than 3 times a week 8. smoke 21 or more cigarettes a day 9. have a history or current condition of drug or alcohol dependence 10. consistently drink more than the appropriate amount of alcohol 11. are planning major changes in their environment during the study period 12. with digestive diseases affecting digestion and absorption and with a history of digestive surgery 13. have food/ medication allergies 14. are judged to be inappropriate as subjects by background survey 15. are pregnant or breast-feeding, or have the will of pregnancy during the study period 16. are participating or are planning to participate in other clinical studies, and had participated within 1 month of obtaining informed consent 17. are judged to be inappropriate as subjects by screening examination 18. plan to travel abroad, including overseas travel, during the study period 19. are judged as inappropriate by investigator

Design outcomes

Primary

MeasureTime frame
Number of Lactobacilli in feces, butyric acid content in feces

Secondary

MeasureTime frame
Defecation survey, analysis of gut microbiota, organic acids content in feces, bile acids content in feces, pH and water content in feces, putrefactive product content in feces, ammonia content in feces, PAC-QOL Japanese version

Countries

Japan

Contacts

Public ContactEiji Yoshikawa

KSO Corporation Sales department

eigyou27@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026